A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Non-Invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Nonalcoholic Fatty Liver Disease (NAFLD)

  • Pianko, Stephen (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date16/01/24 → 16/01/24